Shiva Dustdar and Peter Cowley joined Mark Wilson to talk about whether adoption of the hybrid fund model is increasing in the corporate venturing space, particularity in the healthcare sector.

Speaking at the Global Corporate Venturing Symposium, Mark Wilson, principal at commercialisation consultancy Strategic Technology Bioconsulting, told attendees that corporate venturing capitalists are increasingly adopting hybrid fund models. Wilson moderated a panel discussing hybrid forms of corporate venturing that mix direct and indirect investing, and described the hybrid model as something that‘blends elements of two…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.